Monitoring Agency Report issued by CRISIL Ratings Limited for the utilization of funds raised through Preferential Issue as approved by the Board and members of the Company in their respective meetings held on June 18, 2024 and July 13, 2024, for quarter ended September 30, 2025
ZOTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zota Health Care has submitted the Monitoring Agency Report issued by CRISIL Ratings Limited for the quarter ended September 30, 2025. The report tracks how the company has utilized the proceeds from its earlier Preferential Issue, which was approved by the Board on June 18, 2024 and by members on July 13, 2024. This is a routine regulatory disclosure required for companies that raise funds through preferential allotments, and the actual utilization details would be contained in the full report filed with the exchanges. No new fundraising is being announced here — the company is simply updating on how previously raised funds have been deployed.
This is a compliance filing and does not signal any new fundraising, dilution, or change in business direction. Shareholders should review the actual report for details on fund deployment, but the announcement itself is unlikely to move the stock price.